Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AstraZeneca
Company Monitoring Page for AstraZeneca
latest headlines for company on cafepharma
Fri, 03/22/19 - 09:56 am
Tags:
microbiome
,
Seres Therapeutics
,
AstraZeneca
,
stroke
ACC: AstraZeneca's Farxiga chops follow-up CV events by 16% in heart attack patients with diabetes
Fierce Pharma
Mon, 03/18/19 - 12:16 pm
Tags:
AstraZeneca
,
Farxiga
,
American College of Cardiology
3 Top Diabetes Stocks to Watch in March
Yahoo/Motley Fool
Sun, 03/17/19 - 08:04 pm
Tags:
diabetes
,
AstraZeneca
,
DexCom
,
Medtronic
,
devices
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Sat, 03/16/19 - 12:25 pm
Tags:
Roche
,
SAGE Therapeutics
,
Ligand Pharmaceuticals
,
brexanolone
,
Tecentriq
,
Jazz Pharmaceuticals
,
JZP-110
,
Sanofi
,
Lexicon Pharmaceuticals
,
Zynquista
,
PhaseBio
,
AstraZeneca
,
Amarin
,
Leap Therapeutics
,
Strongbridge
ExcepGen emerges from Y Combinator, taking aim at better proteins for drug discovery
Fierce Biotech
Fri, 03/15/19 - 08:35 pm
Tags:
ExcepGen
,
drug discovery
,
Y Combinator
,
AstraZeneca
AstraZeneca lines up a $20M installment plan to launch a new oncology collaboration with microbiome player Seres
Endpoints
Mon, 03/11/19 - 10:13 pm
Tags:
AstraZeneca
,
oncology
,
microbiome
,
Seres Therapeutics
Was AstraZeneca CEO Pascal Soriot happy with his $14.8M in '18 compensation? Probably not so much
Endpoints
Tue, 03/5/19 - 12:01 pm
Tags:
AstraZeneca
,
Pascal Soriot
,
Pharma CEOs
,
executive pay
AstraZeneca gets FDA expanded approval for Farxiga and Xigduo XR
Pharmaceutical Business Review
Thu, 02/28/19 - 11:45 pm
Tags:
AstraZeneca
,
type 2 diabetes
,
Farxiga
,
Xigduo XR
,
FDA
AstraZeneca, Merck notch another major Lynparza trial win — this time in pancreatic cancer
Endpoints
Tue, 02/26/19 - 09:34 am
Tags:
AstraZeneca
,
Merck
,
pancreatic cancer
,
clinical trials
,
BRCA-mutated prostate cancer
AstraZeneca's clot-fighter Brilinta shows promise in diabetics with heart disease in big study
Endpoints
Mon, 02/25/19 - 09:50 am
Tags:
AstraZeneca
,
Brilinta
,
diabetes
,
blood thinner
,
clinical trials
The fighter, the saint, and the odd man out: the executives who will defend pharma before Congress
Stat
Thu, 02/21/19 - 12:41 pm
Tags:
drug pricing
,
US Congress
,
Donald Trump
,
Richard Gonzalez
,
AbbVie
,
Ken Frazier
,
Merck
,
JNJ
,
Jennifer Taubert
,
Olivier Brandicourt
,
Sanofi
,
Pascal Soriot
,
AstraZeneca
,
Giovanni Caforio
,
Bristol-Myers Squibb
,
Albert Bourla
,
Pfizer
2 Pharma Stocks in the Middle of an Oncology Sales Explosion
Motley Fool
Tue, 02/19/19 - 08:01 pm
Tags:
oncology
,
Roche
,
AbbVie
,
AstraZeneca
AZ’s CEO dismisses “fake news” about his imminent departure
Pharmaforum
Thu, 02/14/19 - 12:00 pm
Tags:
AstraZeneca
,
Pharma CEOs
,
Pascal Soriot
AstraZeneca's (AZN) Q4 Earnings Beat, New Drugs Drive Sales
Yahoo/Zacks.com
Thu, 02/14/19 - 09:51 am
Tags:
earnings
,
AstraZeneca
AstraZeneca sweeps away the MedImmune name as CEO Soriot restructures R&D
Endpoints
Thu, 02/14/19 - 09:43 am
Tags:
AstraZeneca
,
MedImmune
,
R&D
,
restructring
With Obesity on the Continued Rise in the U.S., More Anti-Obesity Drugs Are Heading for the Market
BioSpace
Wed, 02/13/19 - 10:06 am
Tags:
obesity
,
Sanofi
,
Novo Nordisk
,
AstraZeneca
Powerful Senate committee invites pharma executives to testify
Reuters
Tue, 02/5/19 - 11:31 pm
Tags:
Senate
,
drug pricing
,
AbbVie
,
AstraZeneca
,
Bristol-Myers Squibb
,
JNJ
,
Merck
,
Pfizer
,
Sanofi
AZ’s lung drug gets fast development in EU and US
Pharmaforum
Tue, 02/5/19 - 09:49 am
Tags:
AstraZeneca
,
MEDI8897
,
RSV
,
Europe
,
fast track
AstraZeneca’s Forxiga recommended for marketing authorization in EU
Pharmaceutical Business Review
Mon, 02/4/19 - 09:52 am
Tags:
EMA
,
AstraZeneca
,
Forxiga
,
type 1 diabetes
,
CHMP
AstraZeneca and UPMC Health Plan Form Unique Outcome Based Agreement
CP Wire
Mon, 01/28/19 - 12:08 pm
Tags:
AstraZeneca
,
Brilinta
,
outcomes-based contracts
Pages
« first
‹ previous
…
54
55
56
57
58
59
60
61
62
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.